Pentraxin 3, a new biomarker for the diagnosis and management of PJI in primary and revision hip arthroplasty. — Giandomenico Logroscino (2023) | RDL Network
Pentraxin 3, a new biomarker for the diagnosis and management of PJI in primary and revision hip arthroplasty.
Article 2023 en
Authors
GL
Giandomenico Logroscino
AF
Andrea Fidanza
IG
Ilaria Giusti
Abstract
1 min read
An increase in PTX3 protein concentration in the synovial fluid of patients undergoing implant revision has a strong diagnostic capacity for periprosthetic joint infection, showing 97% specificity.
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.